AntlerA Leverages Precision-engineered Protein Therapeutic Platform to Harness Body’s Regenerative Potential
SAN FRANCISCO, Aug. 27, 2019 /PRNewswire/ -- AntlerA is leveraging a precision-engineered programmable Wnt pathway agonist platform to develop drugs that...